<DOC>
	<DOCNO>NCT01758939</DOCNO>
	<brief_summary>Retrospective prospective cohort study aim Assessing predictor response antiviral combine therapy pegylated Interferon ( Both type : Alfa 2 A Alfa 2 B ) hepatitis C virus infect Egyptian patient .</brief_summary>
	<brief_title>Predictors Response Combined Pegylated Interferon Ribavirin Chronic Hepatitis C Infected Egyptian Patients</brief_title>
	<detailed_description>Retrospective prospective cohort study conduct HCV infect patient treat Interferon alpha therapy , retrospective part study include data patient retrieve medical record period September 2006 till January 2011 . Then January 2011 study become prospective national study . Responders therapy define normalization serum alanine aminotransferase ( ALT ) absence detectable serum HCV RNA end treatment ( 48 week ) . Relapsed responder therapy define normalization serum ALT absence detectable serum HCV RNA end treatment increase serum ALT presence HCV RNA follow-up 72 week ) . Non-responders define elevated serum ALT presence HCV RNA end treatment . All patient sign write informed consent share clinical registry data biological sample . Sub-studies conduct subgroups patient share main study sign write informed consent .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>Age : eighteen year 60 Detectable HCV RNA serum PCR ALT level range normal three fold elevation . Minimum hematological value hemoglobin 10.5 g/dl female , 12g/dl male ; white blood count 3Ã—109/L ; platelet count less 100,000/mm3 . Bilirubin , albumin , prothrombin time creatinine within normal limit . A suitable method assessment fibrosis lik liver biopsy fibroscan do start treatment assess degree necroinflammatory response HCV , subgrouped HAI score system mild , moderate &amp; severe . Decompensated cirrhosis Other cause liver disease Autoimmune disorder Uncontrolled diabetes Thyroid dysfunction Neurological cardiovascular disease Malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Peg Interferon ,</keyword>
	<keyword>Ribavirin ,</keyword>
	<keyword>HCV ,</keyword>
	<keyword>Genotype IV .</keyword>
</DOC>